Enrique Z Fisman Selected Research

Bezafibrate

10/2016	Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.
1/2016	Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
1/2014	Bezafibrate treatment is associated with a reduced rate of re-hospitalization in smokers after acute coronary syndrome.
1/2014	Comparison of statin alone versus bezafibrate and statin combination in patients with diabetes mellitus and acute coronary syndrome.
11/2012	Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
10/2012	Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.
1/2009	Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment.
6/2008	Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
1/2008	Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
12/2007	C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrique Z Fisman Research Topics

Disease

23	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 01/2002
20	Type 2 Diabetes Mellitus (MODY) 11/2021 - 04/2002
16	Insulin Resistance 11/2021 - 12/2002
14	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2014 - 12/2002
13	Dyslipidemias (Dyslipidemia) 11/2021 - 11/2004
13	Infarction (Infarctions) 10/2016 - 05/2002
12	Heart Failure 01/2017 - 09/2002
12	Hypertension (High Blood Pressure) 09/2015 - 01/2002
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 12/2002
11	Myocardial Infarction 01/2014 - 04/2002
7	Atherosclerosis 12/2014 - 09/2003
6	Acute Coronary Syndrome 01/2020 - 12/2007
6	Diabetes Mellitus 10/2019 - 01/2004
6	Coronary Disease (Coronary Heart Disease) 06/2014 - 04/2004
5	Hypertriglyceridemia 01/2016 - 06/2005
5	Obesity 09/2015 - 12/2002
4	Thrombosis (Thrombus) 01/2014 - 01/2012
4	Heart Diseases (Heart Disease) 07/2009 - 05/2004
3	Myocardial Ischemia (Ischemic Heart Diseases) 09/2015 - 05/2004
3	Inflammation (Inflammations) 06/2014 - 10/2010
3	Ischemic Stroke 01/2014 - 07/2006
3	Edema (Dropsy) 11/2012 - 05/2004
3	Neoplasms (Cancer) 10/2010 - 04/2004
3	Lactic Acidosis 07/2009 - 05/2004
2	Hyperlipidemias (Hyperlipidemia) 09/2015 - 09/2006
2	Left Ventricular Dysfunction 09/2015 - 10/2010
2	Ischemia 01/2014 - 01/2012
2	Weight Gain 11/2012 - 07/2009
2	Atherosclerotic Plaque (Atheroma) 11/2012 - 10/2010
2	Overweight 11/2012 - 09/2005
2	Unstable Angina 10/2010 - 07/2006
2	Renal Insufficiency (Renal Failure) 07/2009 - 01/2003
2	Body Weight (Weight, Body) 07/2009 - 10/2005
2	Diarrhea 01/2008 - 05/2004
2	Vascular Diseases (Vascular Disease) 01/2008 - 05/2004
2	Hyperinsulinism (Hyperinsulinemia) 01/2004 - 12/2002
1	Magnesium Deficiency (Deficiency, Magnesium) 10/2019

Drug/Important Bio-Agent (IBA)

23	BezafibrateIBA 10/2016 - 05/2002
19	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 09/2002
12	Triglycerides (Triacylglycerol)IBA 01/2016 - 12/2004
10	LipidsIBA 11/2021 - 04/2002
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014 - 12/2004
10	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2012 - 03/2003
9	HDL CholesterolIBA 01/2012 - 12/2004
8	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2004
8	Fibric Acids (Fibrates)IBA 11/2012 - 12/2004
7	CholesterolIBA 01/2012 - 05/2004
7	Insulin (Novolin)FDA Link 07/2009 - 03/2003
6	Blood Glucose (Blood Sugar)IBA 01/2017 - 01/2004
6	LDL CholesterolIBA 09/2015 - 06/2005
6	CytokinesIBA 12/2014 - 09/2003
6	CalciumIBA 01/2008 - 04/2002
5	oxidized low density lipoproteinIBA 12/2014 - 01/2008
5	LigandsIBA 01/2009 - 05/2004
4	Pharmaceutical PreparationsIBA 09/2015 - 04/2002
4	Hypoglycemic Agents (Hypoglycemics)IBA 09/2015 - 05/2004
4	BiguanidesIBA 09/2015 - 05/2004
4	ThiazolidinedionesIBA 11/2012 - 05/2004
3	InterleukinsIBA 01/2017 - 09/2003
3	AdiponectinIBA 09/2015 - 03/2007
3	LDL Lipoproteins (beta Lipoproteins)IBA 12/2014 - 09/2006
3	Blood Coagulation Factors (Coagulation Factor)IBA 12/2014 - 05/2004
3	Biological ProductsIBA 06/2014 - 01/2011
3	Fenofibrate (CiL)FDA LinkGeneric 10/2012 - 09/2006
3	Glyburide (Glibenclamide)FDA LinkGeneric 07/2009 - 05/2004
3	Adenosine Triphosphate (ATP)IBA 01/2008 - 03/2003
3	Nifedipine (Adalat)FDA LinkGeneric 04/2007 - 06/2002
3	fibric acidIBA 07/2006 - 05/2005
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2004 - 12/2002
2	IncretinsIBA 11/2021 - 07/2009
2	SodiumIBA 01/2019 - 12/2002
2	VildagliptinIBA 01/2017 - 06/2012
2	HDL LipoproteinsIBA 12/2014 - 01/2008
2	Lipoproteins (Lipoprotein)IBA 12/2014 - 10/2012
2	Nonesterified Fatty Acids (NEFA)IBA 12/2014 - 11/2012
2	PPAR gammaIBA 11/2012 - 09/2005
2	Therapeutic UsesIBA 10/2012 - 12/2004
2	Interleukin-6 (Interleukin 6)IBA 10/2010 - 07/2006
2	Simvastatin (Zocor)FDA LinkGeneric 06/2010 - 01/2008
2	LeptinIBA 07/2009 - 01/2004
2	Coenzyme A (CoA)IBA 01/2008 - 09/2006
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2008 - 05/2004
2	HomocysteineIBA 01/2008 - 05/2004
2	Oxidoreductases (Dehydrogenase)IBA 01/2008 - 09/2006
2	Ezetimibe (Zetia)FDA Link 01/2008 - 09/2006
2	Potassium Channels (Potassium Channel)IBA 01/2008 - 05/2004
2	Vitamin B Complex (B Vitamins)IBA 01/2008 - 05/2004
2	C-Reactive ProteinIBA 12/2007 - 07/2006
2	CreatinineIBA 03/2004 - 04/2002
2	Ramipril (Altace)FDA LinkGeneric 01/2004 - 12/2002
2	Angiotensin Receptor AntagonistsIBA 01/2004 - 04/2002
2	moexipril (Perdix)FDA LinkGeneric 01/2003 - 12/2002
2	Estrogens (Estrogen)FDA Link 01/2003 - 12/2002
1	Calcineurin InhibitorsIBA 10/2019

Therapy/Procedure

18	Therapeutics 01/2019 - 03/2003
4	Secondary Prevention 07/2006 - 04/2004
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 01/2013
3	Stents 01/2014 - 01/2012
2	Heart Transplantation (Grafting, Heart) 10/2019 - 01/2019
2	Cardiac Rehabilitation 01/2017 - 01/2004